153 related articles for article (PubMed ID: 36418025)
21. Improving clinical trials using Bayesian adaptive designs: a breast cancer example.
Hong W; McLachlan SA; Moore M; Mahar RK
BMC Med Res Methodol; 2022 May; 22(1):133. PubMed ID: 35508968
[TBL] [Abstract][Full Text] [Related]
22. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
Gordon Lan KK; Wittes JT
Clin Trials; 2012 Oct; 9(5):561-9. PubMed ID: 22865839
[TBL] [Abstract][Full Text] [Related]
23. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
24. Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity.
Liu F; Walters SJ; Julious SA
BMC Med Res Methodol; 2017 Oct; 17(1):149. PubMed ID: 28969588
[TBL] [Abstract][Full Text] [Related]
25. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
26. Bayesian basket trial design with false-discovery rate control.
Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
[TBL] [Abstract][Full Text] [Related]
27. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ryan EG; Brock K; Gates S; Slade D
BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
[TBL] [Abstract][Full Text] [Related]
28. Bayesian adaptive decision-theoretic designs for multi-arm multi-stage clinical trials.
Bassi A; Berkhof J; de Jong D; van de Ven PM
Stat Methods Med Res; 2021 Mar; 30(3):717-730. PubMed ID: 33243087
[TBL] [Abstract][Full Text] [Related]
29. Bayesian sample size determination for a Phase III clinical trial with diluted treatment effect.
Zhang YY; Ting N
J Biopharm Stat; 2018; 28(6):1119-1142. PubMed ID: 29513608
[TBL] [Abstract][Full Text] [Related]
30. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
[TBL] [Abstract][Full Text] [Related]
31. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
Berry SM; Broglio KR; Groshen S; Berry DA
Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
[TBL] [Abstract][Full Text] [Related]
32. Flexible Bayesian subgroup analysis in early and confirmatory trials.
Bunn V; Liu R; Lin J; Lin J
Contemp Clin Trials; 2020 Nov; 98():106149. PubMed ID: 32942055
[TBL] [Abstract][Full Text] [Related]
33. Bayesian single-to-double arm transition design using both short-term and long-term endpoints.
Xu T; Shi H; Lin R
Pharm Stat; 2023; 22(4):588-604. PubMed ID: 36755420
[TBL] [Abstract][Full Text] [Related]
34. Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.
Turner RM; Clements MN; Quartagno M; Cornelius V; Cro S; Ford D; Tweed CD; Walker AS; White IR
Stat Med; 2023 Apr; 42(8):1127-1138. PubMed ID: 36661242
[TBL] [Abstract][Full Text] [Related]
35. Small-sample behavior of novel phase I cancer trial designs.
Oron AP; Hoff PD
Clin Trials; 2013 Feb; 10(1):63-80. PubMed ID: 23345304
[TBL] [Abstract][Full Text] [Related]
36. Frequentist operating characteristics of Bayesian optimal designs via simulation.
Zhang Y; Trippa L; Parmigiani G
Stat Med; 2019 Sep; 38(21):4026-4039. PubMed ID: 31215685
[TBL] [Abstract][Full Text] [Related]
37. Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.
Kunzmann K; Grayling MJ; Lee KM; Robertson DS; Rufibach K; Wason JMS
Stat Med; 2022 Feb; 41(5):877-890. PubMed ID: 35023184
[TBL] [Abstract][Full Text] [Related]
38. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
39. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
Moatti M; Chevret S; Zohar S; Rosenberger WF
Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
[TBL] [Abstract][Full Text] [Related]
40. An adaptive power prior for sequential clinical trials - Application to bridging studies.
Ollier A; Morita S; Ursino M; Zohar S
Stat Methods Med Res; 2020 Aug; 29(8):2282-2294. PubMed ID: 31729275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
